Alaunos Therapeutics
Nasdaq TCRT · Fort Lauderdale, FL
Works in Cardiovascular · Dermatology · GI & liver · Hematology · Immunology · Metabolic & endocrine · Neurology · Oncology · Renal & urogenital · Respiratory · Women's health
Alaunos Therapeutics is a clinical trial sponsor based in Fort Lauderdale, FL, listed as Nasdaq TCRT. It has no active clinical trials as lead sponsor; its trials since 2021 were across 11 therapeutic areas. Since 2021 it has completed 13 trials and stopped 14 early.
Trial track record · since 2021
Financials · Nasdaq TCRT
Pipeline · 0 active trials
No active trials with this company as lead sponsor.
Questions about Alaunos Therapeutics
Alaunos Therapeutics has no active clinical trials as lead sponsor on ClinicalTrials.gov. Since 2021 it has completed 13 trials and stopped 14 early.
Alaunos Therapeutics is based in Fort Lauderdale, FL and is listed as Nasdaq TCRT. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Alaunos Therapeutics; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-15.
Approve Suite is not affiliated with Alaunos Therapeutics. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.